Skip to content

Genetic Susceptibility to Radiation Induced Thyroid Cancer

Genetic Susceptibility to Radiation Induced Thyroid Cancer

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04139096
Enrollment
60
Registered
2019-10-25
Start date
2019-09-22
Completion date
2021-09-22
Last updated
2026-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Genetic Susceptibility, Radiation Exposure, Thyroid Neoplasms

Brief summary

Case control on thyroid cancer occuring in a cohort of 7300 subjects treated during their childhood, mostly by radiotherapy, for a skin Angioma at Gustave Roussy, Villejuif France between 1947 and 1973. This case control study, which is included in a larger european project, aims to investigate the DNA variant interacting with the risk of radiation induced thyroid cancer after irradiation. The sutdy is planed to include about 30 cases and 30 controls. Matching criteria are date of birth, gender, and age at irradiation.

Interventions

None listed

Sponsors

Institut National de la Santé Et de la Recherche Médicale, France
Lead SponsorOTHER_GOV

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Diganosis of thyroid cancer during the followup or selected as a control matched on gender, date of birth and age at skin hemangioma diagnosis.

Exclusion criteria

No available adress Refusal

Design outcomes

Primary

MeasureTime frameDescription
Number of Differentiated thyroid carcinomaFrom hemangioma diagnosis to the end of the followup, in average 45 years after hemangioma diagnosisNumber of differentiated thyroid carcinoma occuring in a cohort of subjects treated for a skin hemangioma during the follow-up

Countries

France

Contacts

PRINCIPAL_INVESTIGATORFlorent de Vathaire, PhD

Institut National de la Santé Et de la Recherche Médicale, France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 21, 2026